|
WBPhenotype:0002087
|
hydrogen sulfide hypersensitive
|
Animals respond to hydrogen sulfide at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000500
|
acetylcholinesterase inhibitor hypersensitive
|
Animals respond to an acetylcholinesterase inhibitor at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000023
|
serotonin hypersensitive
|
Animals respond to serotonin at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000559
|
calcium channel modulator hypersensitive
|
Animals respond to a calcium channel modulator at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0002059
|
pore forming toxin hypersensitive
|
Animals respond to pore forming toxins at a lower concentration or a shorter exposure compared to control animals. Increased susceptibility to pore forming toxins (e.g. Cry5B from Bacillus thuringiensis) is often measured by a decrease in the rate of survival in the presence of pore forming toxins compared to controls. |
|
WBPhenotype:0000486
|
colchicine hypersensitive
|
Animals respond to colchicine at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0001419
|
emetine hypersensitive
|
Animals respond to emetine at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0002057
|
Bacillus thuringiensis toxin hypersensitive
|
Animals respond to Bacillus thuringiensis toxins (Bt toxins) at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000341
|
imipramine hypersensitive
|
Animals respond to imipramine at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0001879
|
hydroxyurea hypersensitive
|
Animals respond to hydroxyurea at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000488
|
chloroquine hypersensitive
|
Animals respond to chloroquine at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000332
|
inhibitors of sodium potassium ATPase hypersensitive
|
Animals respond to inhibitors of sodium potassium ATPase at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0001579
|
cholinergic agonist hypersensitive
|
Animals respond to a cholinergic agonist at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000008
|
anesthetic hypersensitive
|
Animals respond to anesthetic at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000214
|
alpha amanitin hypersensitive
|
Animals respond to alpha amanitin at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000789
|
fluoxetine hypersensitive
|
Animals respond to fluoxetine at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0001205
|
muscimol hypersensitive
|
Animals respond to muscimol at a lower concentration or a shorter exposure compared to control animals. |
|
WBPhenotype:0000382
|
serotonin reuptake inhibitor hypersensitive
|
Animals respond to serotonin reuptake inhibitors at a lower concentration or a shorter exposure compared to control animals. |
